NSG BioLabs
Founded with a focus on supporting early-stage biotech companies, NSG BioLabs offers state-of-the-art equipment, efficient operations, capital efficiency, the expertise of world-class teams and global networks to incubate and assist emerging life sciences companies.
NSG BioLabs doubles capacity with new site
NSG BioLabs doubles capacity with new site
The expansion aims to facilitate the growth of promising biotech companies.
Most Read
1. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 2. Neurological disorders and aging boost brain-computer interface market 3. Cardiac monitoring devices market to hit $37.88b by 2031 4. AJJ Medtech hits $8m order book with $3m green supply deal 5. Global prescription drugs market to reach $2.26t by 2034Resource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation